Anti-S100A8 for treating leukemia
US10894082B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 2016 |
| Grant date | Jan 19, 2021 |
| Priority date | — |
| Expiry date | Feb 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present description relates to an anti-S1008 protein for treating leukemia. More specifically, is disclosed anti-S100A8 antibody that specifically binds to a portion of S100A8 protein and/or a S100A8/S100A9 heterodimer for treating leukemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.